Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 7291-7300 Newer>

BusinessWeek March 31, 2011	Johnson & Johnson's Recall Rap Sheet Fifteen months of recalls of everything from artificial hips to Tylenol.
The Motley Fool March 31, 2011 Brian Orelli	Johnson & Johnson Hires a Babysitter J&J tries to turn the OTC business around; the McNeil Consumer Health care unit will now be headed up by Patrick Mutchler, previously the head of the health-care giant's baby products..
The Motley Fool March 31, 2011 Todd Wenning	Dividend Sector Review: Pharmaceuticals These pharmaceutical stocks generate an adequate amount of free cash flow to fund their well above-average dividend yields.
The Motley Fool March 31, 2011 David Williamson	HCA Leads the Way HCA, the for-profit hospital company, returned to the publicly traded stock market in dramatic fashion earlier this month, and there has been much rejoicing by shareholders since.
The Motley Fool March 31, 2011 Brian Orelli	Drug Warning Labels: The Good, Bad, and Ugly Once a drug is approved, investors can't fall asleep and ignore FDA announcements about drugs. They come in different varieties, but warnings tend to be of the bad and ugly variety more often than the good.
The Motley Fool March 31, 2011 Brian Orelli	Hepatitis C Drugs Heat Up The current hepatitis C drugs stink. Who's ahead in the race to find new ones?
The Motley Fool March 31, 2011 David Williamson	Embarking on a Profitable Quest Quest Diagnostics has been busy, snapping up a pair of smaller players and seeing its share price recover to near 52-week highs. Let's take a look at what these acquisitions mean going forward.
The Motley Fool March 31, 2011 Brian Orelli	Better Buy? Seattle Genetics or ImmunoGen Battle of the heat-seeking cellular missiles.
The Motley Fool March 31, 2011 Brian Orelli	Gilead's Long-Term Cancer Fight An academic partnership is a good sign it's serious.
The Motley Fool March 30, 2011 Brian Orelli	Valeant Vultures Will Cephalon manage to rebuff Valeant's advances?
<Older 7291-7300 Newer> Return to current articles.